PMA device
Synchromed II Pump Remediation
Medtronic, Inc. · Pump, Infusion, Implanted, Programmable (LKK, Class III) · First FDA decision Sep 12, 2003, newest Dec 5, 2017Chronic pain
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
10
PMA pathway
Device trials
14
Naming "Synchromed II"
MAUDE reports
59,554
Brand "Synchromed II", since 2015
PubMed studies
37
Mentioning "Synchromed II"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Synchromed II Pump Remediation
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 10 decisions filed under this name.
- SYNCHROMED II PUMP REMEDIATIONPMA supplement
P860004-S268 · Decided Dec 5, 2017 · 305 days after receipt · Normal 180 Day Track
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
- SYNCHROMED II IMPLANTABLE INFUSION PUMPPMA supplement
P860004-S243 · Decided Jul 22, 2016 · 255 days after receipt · Normal 180 Day Track
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
- SYNCHROMED II PROGRAMMABLE INFUSION PUMPPMA supplement
P860004-S224 · Decided Nov 24, 2015 · 267 days after receipt · Normal 180 Day Track
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
3 more FDA decisions with a free account
Older decisions: P860004-S089, P860004-S076, P860004-S070, P860004-S056
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Synchromed II", any status and sponsor, newest update first.
National Cancer Institute (NCI)NIH
NCT03366155 · 24 participants · Start Jun 24, 2019 · Primary completion Nov 13, 2025
Device: Codman 3000 constant flow pump catheter; Medtronic SynchroMed II Pump · For: Colorectal Cancer; Liver Metastases; Colorectal Adenocarcinoma and 2 more
Sites: Bethesda, Maryland
Columbia UniversityAcademic, hospital or other
NCT03154996 · 5 participants · Start Jan 18, 2018 · Primary completion Aug 20, 2021
Device: Synchromed II infusion pumps · For: Gliomas
Sites: New York, New York
Wake Forest University Health SciencesAcademic, hospital or other
NCT05674240 · 30 participants · Start Dec 6, 2022 · Primary completion Mar 20, 2026
Device: Intrathecal Targeted Drug Delivery · For: Cancer Pain; Chronic Pain; Cancer Associated Pain and 1 more
Sites: Oshkosh, Wisconsin
11 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Synchromed II", and for the whole product code for context.
This brand
59,554 reports: 20,414 malfunction, 38,964 injury, 173 death
Whole product code LKK
71,356 reports: 25,333 malfunction, 45,674 injury, 326 death
Newest reports for this brand
- SYNCHROMED IIInjury
MEDTRONIC PUERTO RICO OPERATIONS CO.
3004209178-2026-18520 · Received Oct 30, 2026 · Event dated Oct 28, 2026
Device type: Pump, Infusion, Implanted, Programmable (LKK)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Device Embedded In Tissue or Plaque; Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
- SYNCHROMED IIMalfunction
MEDTRONIC PUERTO RICO OPERATIONS CO.
3004209178-2026-18548 · Received Oct 30, 2026 · Event dated Sep 1, 2026
Device type: Pump, Infusion, Implanted, Programmable (LKK)
Device problem as coded: Insufficient Flow or Under Infusion
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- SYNCHROMED IIInjury
MEDTRONIC PUERTO RICO OPERATIONS CO.
3004209178-2026-18463 · Received Oct 29, 2026 · Event dated Oct 1, 2026
Device type: Pump, Infusion, Implanted, Programmable (LKK)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Loss of consciousness
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2201-2026 · Started Apr 8, 2026 · Posted by FDA May 14, 2026
Reason given: Software issue: When programming the SynchroMed Pump with the A810 CP App in Flex Infusion Mode, the infusion steps should automatically be arranged in consecutive order, from earliest to latest. However, in rare cases, the steps may be displayed out of order. If this occurs, the programmed Flex Infusion schedule will...
Cause as FDA categorized it: Under Investigation by firm · Device type: Pump, Infusion, Implanted, Programmable (LKK)
- A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion System.Open, Classified
Z-1506-2025 · Started Jan 9, 2025 · Posted by FDA Apr 1, 2025
Reason given: Product complaints were received describing the A820 myPTM app taking longer than expected for patients to interact with their implantable pump.
Cause as FDA categorized it: Under Investigation by firm · Device type: Pump, Infusion, Implanted, Programmable (LKK)
- Medtronic Ascenda Intrathecal Catheter, Models: a) 8780 (114 cm); b) 8781 (140 cm); c) 8784 (catheter pump revision kit)Open, Classified
Z-2352-2024 · Started May 10, 2024 · Posted by FDA Jul 12, 2024
Reason given: Design update to the Ascenda Intrathecal Catheter Models 8780, 8781, and 8784. The intent of the design update is to reduce the potential for tissue growth into the Ascenda catheter connector which may potentially lead to catheter occlusion.
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Implanted, Programmable (LKK)
37 more recall records with a free account
Published research
The most relevant PubMed records for "Synchromed II"[tiab]. The summary above synthesizes these.
- "Sonology" of programmable intrathecal pumps.
Saulino M, Gofeld M · Neuromodulation · 2014
- Implantable systems for neurological chronotherapy.
Lee SH, Hofstede RP, Noriega de la Colina A, et al. · Adv Drug Deliv Rev · 2025Review
- Accuracy and Precision of the SynchroMed II Pump.
Farid R, Binz K, Emerson JA, et al. · Neuromodulation · 2019
- Transcutaneous spinal stimulation in patients with intrathecal baclofen pump delivery system: A preliminary safety study.
Lopez J, Forrest GF, Engel-Haber E, et al. · Front Neurosci · 2022
- Clinical accuracy and safety using the SynchroMed II intrathecal drug infusion pump.
Wesemann K, Coffey RJ, Wallace MS, et al. · Reg Anesth Pain Med · 2014Evaluation Study, Research Support, Non-U.S. Gov't
- Malfunction of SynchroMed II baclofen pump delivers a near-lethal baclofen overdose.
Sgouros S, Charalambides C, Matsota P, et al. · Pediatr Neurosurg · 2010Case Reports
- [Complications of intrathecal baclofen therapy].
Paskhin DL, Dekopov AV, Tomsky AA, et al. · Zh Vopr Neirokhir Im N N Burdenko · 2017
- SynchroMed II intrathecal pump memory errors due to repeated magnetic resonance imaging.
Kosturakis A, Gebhardt R · Pain Physician · 2012Case Reports
- Intrathecal Pump: An Abrupt Intermittent Pump Failure.
Riordan J, Murphy P · Neuromodulation · 2015Case Reports
- Continuous intracerebroventricular morphine infusion for intractable neuropathic pain.
Sun B, Guo X, Du X, et al. · BMC Neurol · 2026
- Effect of intrathecal baclofen concentration on spasticity control: case series.
Saval A, Chiodo AE · J Spinal Cord Med · 2008Case Reports
- Intrathecal Baclofen for Severe Spasticity: Longitudinal Data From the Product Surveillance Registry.
Schiess MC, Eldabe S, Konrad P, et al. · Neuromodulation · 2020Multicenter Study
Other devices of this type
Also filed under product code LKK.
- SynchroMed Infusion System, Ascenda Intrathecal CathetersMedtronic, Inc. · PMA 2026
- Prometra Programmable Infusion Pump SystemInfusyn Therapeutics, LLC · PMA 2025
- Implantable System for RemodulinMedtronic, Inc. · PMA 2021
- Medstream Programmable Infusion SystemIntera Oncology · PMA 2014
- IsoMed Infusion SystemMedtronic, Inc. · PMA 2023
- INFUSAID Implantable Infusion Pump and AccessoriesIntera Oncology · PMA 2020
- Medtronic(R) Synchromed(Tm) Pump & Infusion SystemMedtronic, Inc. · PMA 2018
- 3000 Series Implantable Infusion Pump and the MedStream Programmable Infusion System and AccessoriesIntera Oncology · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.